Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells

MLA

Pan, Jingxuan, et al. “Differential Impact of Structurally Different Anti-Diabetic Drugs on Proliferation and Chemosensitivity of Acute Lymphoblastic Leukemia Cells.” Cell Cycle, vol. 11, no. 12, June 2012, pp. 2314–26. EBSCOhost, https://doi.org/10.4161/cc.20770.

APA

Pan, J., Chen, C., Jin, Y., Fuentes-Mattei, E., Velazquez-Tores, G., Benito, J. M., Konopleva, M., Andreeff, M., Lee, M.-H., & Yeung, S.-C. J. (2012). Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. Cell Cycle, 11(12), 2314–2326. https://doi.org/10.4161/cc.20770

Chicago

Pan, Jingxuan, Chun Chen, Yanli Jin, Enrique Fuentes-Mattei, Guermarie Velazquez-Tores, Juliana Maria Benito, Marina Konopleva, Michael Andreeff, Mong-Hong Lee, and Sai-Ching J. Yeung. 2012. “Differential Impact of Structurally Different Anti-Diabetic Drugs on Proliferation and Chemosensitivity of Acute Lymphoblastic Leukemia Cells.” Cell Cycle 11 (12): 2314–26. doi:10.4161/cc.20770.